Blood tests for Alzheimer’s disease biomarkers are rapidly advancing, offering the promise of earlier detection and improved monitoring. However, while…
Read More
Five Breakthroughs in Alzheimer’s Care and Treatment in 2025
Alzheimer’s disease remains one of the most challenging neurological conditions, affecting millions worldwide. In 2025, researchers and clinicians have made…
Read More
Novo Nordisk Faces Setback as Alzheimer’s Trial for Ozempic Fails
COPENHAGEN — Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and weight‑loss drugs including Ozempic, faced a major…
Read More
